Tumor cells can evade T cell-mediated killing by upregulating the interaction of ligands (such as PD-L1) with the inhibitory receptor PD-1, CTLA-4, and LAG-3, which are expressed on tumor-infiltrating T-cells (40). This evidence concerns the gene LAG3 and neoplasm.